Correlation Between VeriSign and SCANDMEDICAL SOLDK-040

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VeriSign and SCANDMEDICAL SOLDK-040 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VeriSign and SCANDMEDICAL SOLDK-040 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VeriSign and SCANDMEDICAL SOLDK 040, you can compare the effects of market volatilities on VeriSign and SCANDMEDICAL SOLDK-040 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VeriSign with a short position of SCANDMEDICAL SOLDK-040. Check out your portfolio center. Please also check ongoing floating volatility patterns of VeriSign and SCANDMEDICAL SOLDK-040.

Diversification Opportunities for VeriSign and SCANDMEDICAL SOLDK-040

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between VeriSign and SCANDMEDICAL is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding VeriSign and SCANDMEDICAL SOLDK 040 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDMEDICAL SOLDK 040 and VeriSign is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VeriSign are associated (or correlated) with SCANDMEDICAL SOLDK-040. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDMEDICAL SOLDK 040 has no effect on the direction of VeriSign i.e., VeriSign and SCANDMEDICAL SOLDK-040 go up and down completely randomly.

Pair Corralation between VeriSign and SCANDMEDICAL SOLDK-040

Assuming the 90 days horizon VeriSign is expected to generate 0.65 times more return on investment than SCANDMEDICAL SOLDK-040. However, VeriSign is 1.54 times less risky than SCANDMEDICAL SOLDK-040. It trades about 0.23 of its potential returns per unit of risk. SCANDMEDICAL SOLDK 040 is currently generating about 0.09 per unit of risk. If you would invest  15,970  in VeriSign on September 1, 2024 and sell it today you would earn a total of  2,155  from holding VeriSign or generate 13.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

VeriSign  vs.  SCANDMEDICAL SOLDK 040

 Performance 
       Timeline  
VeriSign 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in VeriSign are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, VeriSign may actually be approaching a critical reversion point that can send shares even higher in December 2024.
SCANDMEDICAL SOLDK 040 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, SCANDMEDICAL SOLDK-040 is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

VeriSign and SCANDMEDICAL SOLDK-040 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VeriSign and SCANDMEDICAL SOLDK-040

The main advantage of trading using opposite VeriSign and SCANDMEDICAL SOLDK-040 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VeriSign position performs unexpectedly, SCANDMEDICAL SOLDK-040 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDMEDICAL SOLDK-040 will offset losses from the drop in SCANDMEDICAL SOLDK-040's long position.
The idea behind VeriSign and SCANDMEDICAL SOLDK 040 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals